New Approaches to the Diagnosis, Clinical Course, and Goals of Therapy in Multiple Sclerosis and Related Disorders.
The diagnosis, categorization, and treatment of multiple sclerosis (MS) and other demyelinating diseases have shifted over the past decade, and many of the fundamental principles of MS pathogenesis and clinical course are being rewritten. Fundamental issues include selecting the right disease-modifying therapy for someone with active disease and how, or even if, patients with purely progressive MS should be treated. This article provides an overview and introduction to the current thinking in MS diagnosis and therapy with an emphasis on the data-driven and proactive approach that has come to define the current state of the art.
Stephen C
SC
Krieger
D003711:Demyelinating Diseases / Q000000981:diagnostic imaging / Q000276:immunology / Q000628:therapy; D018450:Disease Progression; D006040:Goals; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging / Q000639:trends; D009103:Multiple Sclerosis / Q000000981:diagnostic imaging* / Q000276:immunology / Q000628:therapy*
D007166:Immunosuppressive Agents